Axsome Therapeutics, Inc.
AXSMAPI behind this page
AXSM FY 2025 request
Playground key active
/api/financials?ticker=AXSM&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 638,496 | 385,693 | +65.5% |
Show Product Lines breakouts |
|||
| Product | 633,796 | 381,677 | +66.1% |
| Product · AUVELITY | 507,093 | 291,378 | +74.0% |
| Product · Non Us | 5,179 | 3,518 | +47.2% |
| Product · SUNOSI | 120,093 | 90,299 | +33.0% |
| Product · Symbravo | 6,610 | — | — |
| Product · US | 628,617 | 378,159 | +66.2% |
| Royalty and Milestone Revenue | 4,700 | 4,016 | +17.0% |
| Royalty and Milestone Revenue · Non Us | 4,700 | 4,016 | +17.0% |
| Royalty and Milestone Revenue · SUNOSI | 4,700 | 4,016 | +17.0% |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 47,478 | 33,303 | +42.6% |
| Research & Development | 183,279 | 187,077 | -2.0% |
Show Capitalized Costs Of Unproved Properties Excluded From Amortization By Property Or Project breakouts |
|||
| AXS-05 | 55,312 | 62,877 | -12.0% |
| AXS-07 | 21,421 | 15,587 | +37.4% |
| AXS-12 | 8,482 | 9,362 | -9.4% |
| AXS-14 | 8,485 | 11,881 | -28.6% |
| Solriamfetol | 42,106 | 53,678 | -21.6% |
| Selling, General & Administrative | 570,599 | 411,359 | +38.7% |
| Change In Fair Value Of Contingent Considerations | -2,473 | 28,124 | -108.8% |
| Amortization Of Intangible Assets | 6,375 | 6,392 | -0.3% |
| Total Costs & Expenses | 805,258 | 666,255 | +20.9% |
| Operating Income | -166,762 | -280,562 | +40.6% |
| Investment Income Net | -6,557 | -6,569 | +0.2% |
| Gains Losses On Extinguishment Of Debt | -10,385 | — | — |
| Income Before Taxes | -183,704 | -287,131 | +36.0% |
| Income Tax Expense (Benefit) | 530 | -85 | +723.5% |
| Net Income | -183,174 | -287,216 | +36.2% |
Show Equity Components breakouts |
|||
| Retained Earnings | -183,174 | -287,216 | +36.2% |
| EPS (Basic) | -3.68 | -5.99 | +38.6% |
| EPS (Diluted) | -3.68 | -5.99 | +38.6% |
| Wtd Avg Shares (Basic) | 49,747,178 | 47,914,253 | +3.8% |
| Wtd Avg Shares (Diluted) | 49,747,178 | 47,914,253 | +3.8% |
| Sales & Marketing | 440,402 | 293,355 | +50.1% |
| General & Administrative | 63,273 | 54,204 | +16.7% |
| Interest Expense | 15,928 | 21,581 | -26.2% |
| Interest Income Operating | 9,371 | 15,012 | -37.6% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 322,933 | 315,353 | +2.4% |
| Accounts Receivable | 224,464 | 142,001 | +58.1% |
| Inventory | 27,938 | 15,732 | +77.6% |
| Prepaid Expenses & Other Current Assets | 13,651 | 11,978 | +14.0% |
| Total Current Assets | 588,986 | 485,064 | +21.4% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 562 | 584 | -3.8% |
| Operating Lease Right-of-Use Assets | 20,858 | 5,383 | +287.5% |
| Goodwill | 12,042 | 12,042 | 0.0% |
| Other Inventory Noncurrent | 26,838 | 18,531 | +44.8% |
| Total Assets | 689,805 | 568,498 | +21.3% |
| Intangible Assets | 40,519 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 40,519 | 46,894 | -13.6% |
| Current Liabilities | |||
| Accounts Payable | 65,537 | 71,997 | -9.0% |
| Accounts Payable And Other Accrued Liabilities Current | 232,853 | 147,987 | +57.3% |
| Operating Lease Liability Current | 434 | 1,835 | -76.3% |
| Business Combination Contingent Consideration Liability Current | 10,012 | 8,285 | +20.8% |
Show Business Acquisition breakouts |
|||
| SUNOSI | 10 | — | — |
| Current Portion of Long-Term Debt | 70,000 | — | — |
| Total Current Liabilities | 378,836 | 230,104 | +64.6% |
| Non-Current Liabilities | |||
| Business Combination Contingent Consideration Liability Noncurrent | 77,540 | 91,680 | -15.4% |
Show Business Acquisition breakouts |
|||
| SUNOSI | 77.5 | — | — |
| Long-Term Debt | 117,746 | 180,710 | -34.8% |
| Operating Lease Liabilities | 23,182 | 6,046 | +283.4% |
| Finance Lease Liability Noncurrent | 4,206 | 2,943 | +42.9% |
| Total Liabilities | 601,510 | 511,483 | +17.6% |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Additional Paid In Capital Common Stock | 1,394,251 | 1,179,797 | +18.2% |
| Retained Earnings | -1,305,961 | -1,122,787 | -16.3% |
| Total Stockholders' Equity | 88,295 | 57,015 | +54.9% |
Show Equity Components breakouts |
|||
| Additional Paid In Capital | 1,394,251 | 1,179,797 | +18.2% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | -1,305,961 | -1,122,787 | -16.3% |
| Total Liabilities & Equity | 689,805 | 568,498 | +21.3% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -183,174 | -287,216 | +36.2% |
| Stock-Based Compensation | 93,752 | 85,218 | +10.0% |
| Amortization Of Debt Discount Premium | 1,303 | 2,640 | -50.6% |
Show Equity Components breakouts |
|||
| Warrant | 776 | 1,165 | -33.4% |
| Depreciation | 503 | 532 | -5.5% |
| Gain Loss From Lease Modification | -2,250 | — | — |
| Non Cash Lease Expense | 3,046 | 1,388 | +119.5% |
| Finance Lease Right Of Use Asset Amortization | 2,186 | 1,034 | +111.4% |
| Change in Accounts Receivable | -82,463 | -47,181 | -74.8% |
| Change in Inventory | -10,660 | 744 | -1532.8% |
| Increase Decrease In Prepaid Expense And Other Assets Current | -1,673 | -3,863 | +56.7% |
| Non Current Inventory And Other Assets | -5,010 | -3,183 | -57.4% |
| Change in Accounts Payable | -6,460 | 31,318 | -120.6% |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | 83,743 | 56,065 | +49.4% |
| Increase Decrease In Operating Lease Liability | -535 | -422 | -26.8% |
| Net Cash from Operations | -93,405 | -128,410 | +27.3% |
| Investing Activities | |||
| Capital Expenditures | -480 | -270 | -77.8% |
| Net Cash from Investing | -480 | -270 | -77.8% |
| Financing Activities | |||
| Proceeds From Long Term Lines Of Credit | 330,000 | — | — |
| Debt Issuance Costs | -3,638 | — | — |
| Repayments Of Long Term Debt | -331,988 | — | — |
| Finance Lease Principal Payments | -2,124 | -990 | -114.5% |
| Proceeds From Issuance Of Common Stock | 67,904 | 40,784 | +66.5% |
| Payments Of Stock Issuance Costs | -1,197 | -816 | -46.7% |
| Proceeds From Issuance Of Common Stock Upon Exercise Of Options And Under Employee Stock Purchase Plan | 59,558 | 30,680 | +94.1% |
| Payment Of Contingent Consideration | -9,940 | -7,866 | -26.4% |
| Tax Withholding for Share Compensation | -7,110 | -3,952 | -79.9% |
| Net Cash from Financing | 101,465 | 57,840 | +75.4% |
| Amortization of Financing Costs | 527 | 1,475 | -64.3% |
| Supplemental | |||
| Interest Paid | 14,626 | 19,690 | -25.7% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 23,869 | — | — |
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | 4,510 | 5,355 | -15.8% |
| Decrease In Operating Lease Right- Of- Use Asset Due To Lease Modification | 5,349 | — | — |
| Decrease In Operating Lease Liability Due To Lease Modification | 7,599 | — | — |
| Income Taxes Paid | -180 | — | — |
| Other Cash Flow | |||
| Net Change in Cash | 7,580 | -70,840 | +110.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 322,933 | 315,353 | +2.4% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.